C.B. Fleet has been hit with over 150 Fleet Phospho-Soda lawsuits since 2004. Plaintiffs in the litigation allege that the company was negligent for promoting the double-dose of Phospho-Soda without warning about the risk of kidney failure or heart problems. The FDA has recently warned against taking more than one dose of sodium phosphate in 24 hours.
What You Can Do & How a Fleet Phospho-Soda Lawsuit Can Help
The Schmidt Firm, PLLC is currently accepting Fleet Phospho-Soda induced injury cases in all 50 states. If you or somebody you know was injured by Fleet Phospho-Soda, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.
UPDATE: FDA Safety Warning for Fleet Phospho-Soda
In January 2013, the U.S. Food and Drug Administration (FDA) warned about the life-threatening side effects of taking more than one dose of sodium phosphate per day. According to the Drug Safety Communication, they have received 54 adverse event reports since 1969, including 13 deaths.
What is the problem with Fleet Phospho-Soda?
C.B. Fleet has sold Fleet Phospho-Soda for over 100 years. It was originally sold over-the-counter as a laxative. It contains sodium phosphate, which flushes out the intestines with fluid and frequent bowel movements. Pescription-only sodium phosphate products include Visicol and OsmoPrep.
Fleet Phospho-Soda has a proven track-record of safety at normal doses. The problem is that higher doses (more than one dose in 24 hours) can potentially cause extreme fluid loss, dehydration, kidney damage, heart problems, and death.
During the 1990s, C.B. Fleet began marketing Phospho-Soda as a bowel-cleaning enema product before colonoscopies. They recommended that customers take two doses. Unfortunately, they never evaluated the side effects of double-dosing.
Over the next two decades, researchers published numerous studies and case reports linking high-dose Phospho-Soda to severe, life-threatening complications — especially in people over 55 years old, those with kidney problems, and those on certain medications.
Fleet Phosphate Enema Recall
Despite the warning signs, C.B. Fleet did not immediately Phospho-Soda off the market, change the dosing recommendations, or warn consumers about its dangers. In fact, they waited until after the U.S. Food and Drug Administration (FDA) published a Safety Communication about a type of permanent kidney damage called acute phosphate nephropathy.
The FDA also warned against using over-the-counter sodium phosphate products, such as Phospho-Soda, to clean the bowel before a colonoscopy. Shortly afterward, C.B. Fleet voluntarily recalled Fleet Phospho Soda and Fleet Phospho-Soda EZ-Prep Bowel Cleansing System.
Fleet Phospho-Soda Side Effects
- Acute phosphate nephropathy
- Kidney failure
- Acute colitis
- Electrolyte disturbances
- Cardiac arrhythmia (irregular heartbeat)
- Respiratory distress
- Bowel perforation
- Need for dialysis, surgery, or kidney transplant
- Permanent neurological defects
- Heart attack
- Congestive heart failure
Do I have a Fleet Phospho-Soda Lawsuit?
The Schmidt Firm, PLLC is currently accepting Fleet Phospho-Soda injury cases in all 50 states. If you or somebody you know was injured by Fleet Phospho-Soda, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.